BRCA2 and cancer: Notably, our proposal suggests that—rather than being promoted solely by intrinsic cellular defects—cancer evolution among carriers of at least certain types of BRCA2 mutations may instead be driven by a gene-environment interaction, in which a category of pervasive, naturally occurring compounds trigger “induced haploinsufficiency.”